ACE inhibition in stable coronary artery disease

Comment

Salim Yusuf et al. N Engl J Med. 2005.

. 2005 Mar 3;352(9):937-9; author reply 937-9.

doi: 10.1056/NEJM200503033520919.

No abstract available

Comment on

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.
Heart Outcomes Prevention Evaluation Study Investigators; Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Heart Outcomes Prevention Evaluation Study Investigators, et al. N Engl J Med. 2000 Jan 20;342(3):145-53. doi: 10.1056/NEJM200001203420301. N Engl J Med. 2000. PMID: 10639539 Clinical Trial.
Angiotensin-converting-enzyme inhibition in stable coronary artery disease.
Braunwald E, Domanski MJ, Fowler SE, Geller NL, Gersh BJ, Hsia J, Pfeffer MA, Rice MM, Rosenberg YD, Rouleau JL; PEACE Trial Investigators. Braunwald E, et al. N Engl J Med. 2004 Nov 11;351(20):2058-68. doi: 10.1056/NEJMoa042739. Epub 2004 Nov 7. N Engl J Med. 2004. PMID: 15531767 Free PMC article. Clinical Trial.